Oral Semaglutide Breaks New Ground: FDA Expands Rybelsus Approval to Tackle Cardiovascular Risk in Diabetes Patients
A New Era in Diabetes and Cardiovascular Care The landscape of diabetes management has shifted significantly with the FDA’s expanded…